CION Ameerpet
Common Questions · Reviewed by CION Oncologists · NABH Accredited
Is There a Screening Test for Endometrial Cancer? Not Really.
There is no equivalent of the mammogram or the Pap smear for cancer of the womb lining, and no country runs a population screening programme for it. That sounds like a gap, and women often find it alarming. It is worth understanding why it is not. Screening exists to find cancers that are silent until they are advanced. Endometrial cancer is not silent — it usually announces itself early, through abnormal bleeding, which is why roughly two thirds of cases are caught while still inside the uterus. The protection is real; it just works through your symptoms rather than through an appointment letter.
- No population screening exists — and no major guideline recommends it for women at average risk
- The disease tells you early — bleeding is the signal, and most women act on it
- The Pap smear is not it — that tests the cervix, an entirely different organ
- Lynch syndrome is the exception — genuine surveillance is offered to that defined group
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Why There Is No Screening Programme
A screening programme is not simply a test that exists. It has to satisfy several conditions at once, and cervical screening satisfies all of them beautifully — which is exactly why the contrast is instructive.
- Cervical cancer has a long, silent precancerous phase on a surface you can reach. Abnormal cells sit on the cervix for years before becoming cancer, and a brush can collect them. Endometrial cancer has no comparable accessible precancer stage — hyperplasia exists, but it lives inside the cavity and generally causes bleeding rather than sitting silently.
- Endometrial cancer is not silent. The lining bleeds when something is wrong with it. That is why the disease is usually found early, and why screening would add less than it does in cancers that stay quiet until late.
- The available tests do not perform well in women without symptoms. Ultrasound thresholds were derived in women being investigated for bleeding. Applied to women with no symptoms, they produce a large number of biopsies that find nothing. See endometrial thickness.
- Sampling the lining is too invasive to screen with. An endometrial biopsy is quick and safe, but it is uncomfortable and it is not something you would ask a whole population of well women to have every few years.
The practical consequence is important, and it is the whole point of this page: because there is no test watching for you, your symptoms are doing that job. Which makes reporting them promptly considerably more important than it would be in a cancer with a screening programme.
Did You Know? The absence of screening is not an oversight — it has been studied, and screening asymptomatic women has not been shown to save lives in this disease. A test applied to a whole population has to be accurate enough that it does not generate large numbers of false alarms, and acceptable enough that women will actually attend. Transvaginal ultrasound in women without symptoms produces a great many thickened linings that turn out to be nothing, each leading to a biopsy; and routine endometrial sampling of healthy women is too invasive to be a screening proposition. Against that, a cancer that produces bleeding early, in a woman who reports it, is usually caught at stage 1 anyway. Sources: NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms and Genetic/Familial High-Risk Assessment: Colorectal, Endometrial and Gastric; ESMO Clinical Practice Guidelines for endometrial carcinoma; ACOG guidance on the role of transvaginal ultrasonography in evaluating the endometrium.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
What Protects You Instead
These are the four things that actually reduce your chance of dying of this disease, in rough order of how much they matter.
| What | Why it matters |
|---|---|
| Reporting bleeding promptly | By far the most important. Any bleeding after the menopause — even one episode of brown spotting — needs assessment. So does bleeding between periods or a marked change in your periods. See postmenopausal bleeding. |
| Not accepting a dismissal | The commonest cause of delay is a symptom being attributed to something else — hormone therapy, fibroids, stress, age. If bleeding continues, it needs investigating again regardless of what a previous test showed. |
| Managing your risk factors | Body weight, blood sugar and unopposed oestrogen exposure are the main drivers, and they are partly modifiable. This lowers your chance of getting it at all. See reducing your risk. |
| Knowing your family history | A pattern of bowel, womb or ovarian cancer in the family — particularly at younger ages — may indicate Lynch syndrome, and that is the one situation with genuine surveillance. See family history. |
If you take one thing from this page, take the first row. A single episode of bleeding after the menopause is enough to warrant assessment. You do not need it to happen repeatedly, you do not need it to be heavy, and you do not need to wait and see whether it recurs. Most women who do this find out that nothing is wrong, and that is a good outcome rather than a wasted appointment.
Want Your Own Risk Assessed?
Family history, weight, diabetes, PCOS and hormone use all feed into it — and for a few women it leads to genuine surveillance.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Your Symptoms Are the Screening Programme
Which is why reporting bleeding quickly matters more in this cancer than in almost any other.
The One Group That Does Get Surveillance
Everything above applies to women at average risk. There is one clear exception, and if it applies to you it changes the picture entirely.
Lynch syndrome is an inherited condition affecting the DNA mismatch repair system. It raises the lifetime risk of endometrial cancer substantially — to a level comparable with, and in some genes exceeding, the risk of bowel cancer that the condition is better known for — and it tends to cause disease at a younger age than usual. For women with Lynch syndrome, the calculation that rules out population screening no longer holds, because the underlying risk is so much higher.
- Education about symptoms comes first. Women with Lynch syndrome are counselled to report any abnormal bleeding immediately rather than waiting, which remains the most effective single measure even in this group.
- Periodic sampling and ultrasound are considered. Endometrial sampling and transvaginal ultrasound from a defined age are offered in many centres, with the caveat that their benefit is less firmly established than symptom reporting. See surveillance with Lynch syndrome.
- Risk-reducing hysterectomy is discussed. Removing the uterus and usually the ovaries and tubes once childbearing is complete is a recognised option that substantially reduces risk, and it is a decision made with genetic counselling rather than in a single appointment.
- The family is part of it. A Lynch diagnosis has implications for parents, siblings and children, all of whom may be offered testing. See Lynch syndrome and your family.
How Lynch syndrome is usually identified is worth knowing: every endometrial tumour is now tested for mismatch repair status, both to guide treatment and to flag who should be offered genetic counselling. See MMR and MSI testing and Lynch syndrome and endometrial cancer.
Family History of Bowel or Womb Cancer?
That is the situation where genuine surveillance exists. Genetic counselling can establish whether it applies to you. The opinion is free.
Who Should Have a Conversation About Their Risk
None of these is a reason to be screened, and all of them are reasons to have your risk discussed and to take symptoms seriously.
Strongest signal
Family Pattern of Cancer
Bowel, womb or ovarian cancer in close relatives, particularly under 50 or in more than one generation. See signs it could be Lynch-related.
Common
Significant Excess Weight
The single largest modifiable driver of this disease, because fat tissue produces oestrogen. See obesity and endometrial cancer.
Common
PCOS or Long-Absent Periods
Cycles without ovulation mean no progesterone to oppose oestrogen, year after year. See PCOS and endometrial cancer.
Common
Type 2 Diabetes
Adds risk of its own alongside weight, and is highly prevalent across Telangana and Andhra Pradesh. See diabetes and risk.
Medication
Oestrogen Without Progesterone
Hormone replacement given as oestrogen alone in a woman who still has her uterus removes the brake entirely. See oestrogen-only HRT.
Medication
Hormonal Breast Cancer Treatment
Some treatments thicken the lining. Routine scanning is not recommended; reporting bleeding is. See the breast cancer link.
Where a Cancer Centre Adds Something Without a Screening Test
Fast, accurate assessment of symptoms, and proper genetics for the families who need it.
Scan and biopsy in one visit
Lynch counselling built in
MMR / MSI testing as standard
45-minute consultations
Second opinions welcomed, not resented
Decisions for healing, not billing
Take The Next Step
No Screening Letter Is Coming. Your Symptoms Are the Alarm.
If something has changed, get it looked at. Most of the time it is nothing, and finding that out is quick.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Endometrial Cancer Screening — Frequently Asked Questions
Is there a screening test for endometrial cancer?
No — there is no population screening programme for endometrial cancer anywhere, and no major guideline recommends screening women at average risk. This is a considered position rather than a gap. Screening works best for cancers that stay silent until they are advanced and that have a long, detectable precancerous phase. Endometrial cancer is different: it usually causes abnormal bleeding early, which is why around two thirds of cases are diagnosed while still confined to the uterus. Meanwhile the available tests do not perform well in women without symptoms — ultrasound thresholds derived in women being investigated for bleeding produce many false alarms when applied to healthy women, and sampling the lining is too invasive to use as a screening test.
If there is no screening, how will endometrial cancer be found?
Through your symptoms, which is why they matter so much more in this cancer than in one with a screening programme. The cardinal signal is bleeding after the menopause — any bleeding at all, including a single episode of brown spotting. Before the menopause, the signals are bleeding between periods, unusually heavy or prolonged periods, and a marked change from what is normal for you. Watery or blood-stained discharge also counts. Once reported, the pathway is quick: a transvaginal ultrasound to look at the lining, and usually an outpatient endometrial biopsy that takes a few minutes. Most women investigated this way turn out not to have cancer, and finding that out promptly is the point.
Should I ask for a scan to check my womb lining anyway?
Generally no, if you have no symptoms, and it is worth understanding why the answer is not simply "it cannot hurt". The published thickness thresholds were derived in postmenopausal women being investigated for bleeding, and they answer one narrow question: in this woman, is cancer unlikely enough that a biopsy can reasonably be avoided. Applied to a woman with no symptoms, a thickened measurement found incidentally is a much weaker signal, and acting on it reflexively leads to biopsies that mostly find nothing while causing real anxiety and discomfort. If you have specific risk factors, the sensible step is a conversation about your overall risk rather than a scan.
Who does get surveillance for endometrial cancer?
Women with Lynch syndrome, an inherited condition affecting the DNA mismatch repair system that raises the lifetime risk of endometrial cancer substantially and tends to cause it at a younger age. For this group the calculation that rules out population screening no longer applies, because the underlying risk is so much higher. Surveillance typically combines strong education about reporting any abnormal bleeding immediately — still the most effective single measure — with consideration of periodic endometrial sampling and transvaginal ultrasound from a defined age, and a discussion of risk-reducing hysterectomy once childbearing is complete. It is arranged through genetic counselling rather than as a routine appointment.
Can a blood test detect endometrial cancer early?
Not reliably, and nothing of the kind is recommended for screening. CA-125 is sometimes measured in women already diagnosed with endometrial cancer, particularly where more advanced or aggressive disease is suspected, because it can help assess extent and monitor response. But it is neither sensitive nor specific enough to detect early endometrial cancer in a woman without symptoms: it is normal in many women who have the disease and raised in many who do not, including in benign conditions such as fibroids and endometriosis. Research into blood and sampling-based tests for early detection is genuinely active, but nothing has yet been validated for population screening.
Medical disclaimer: This page explains why there is no population screening programme for endometrial cancer and is reviewed by a CION oncologist, following current NCCN and ESMO guidance. It is general health information and not advice about your own case. Surveillance recommendations for women with Lynch syndrome vary between guidelines and should be arranged through genetic counselling. If you have bleeding after the menopause, or any abnormal bleeding, see a doctor promptly rather than waiting.